Global University Venturing

Tel Aviv University spinout CB4 has been bought by Gap after having raised at least $22m in equity financing.

The cancer drug developer has closed its initial public offering after underwriters exercised the greenshoe option.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

MIT spinout Copious Imaging has been acquired by Anduril Industries for an undisclosed amount.

The small molecule drug developer has raised a series B round that brought its total funding to more than $100m.

CEO Alan Aubrey and CIO Mike Townend are stepping down today, although both will remain employees for six months and consultants thereafter.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

UChicago spinout Pyxis Oncology is aiming to raise more than $153m in its initial public offering, having set a price range of $14 to $16.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The Dundee spinout has raised more than $304m in its IPO in the US, with another $160m secured through a concurrent private placement.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.